New to The Street TV Announces its Business Guest


NEW YORK, Sept. 23, 2022 (GLOBE NEWSWIRE) —  FMW Media’s New to The Street TV declares broadcasting its sponsored program business present Saturday, September 24, 2022, on Bloomberg TV at 6:00 PM ET.

New to The Street’s TV episode #388 will air the next business interviews:

1). PetVivo Holdings, Inc.’s (NASDAQ: PETV) (NASDAQ: PETVW) ($PETV) interview with John Lai, CEO & President.

2). Acurx Pharmaceuticals, Inc.’s (NASDAQ: ACXP) ($ACXP) interview with David Luci, President / CEO.

3). “Unstoppable Segment”Coastal Kapital, LLC’s interviews with Kortney Murray, CEO/Founder, and Chris Murray, Senior Vice-president.

4). “Unstoppable Segment”Blue Castle Ventures LTD’s (CRYPTO: BCVD) ($BCVD) interview with David Rojas, CEO/Founder.

New to The Street TV is airing the Nasdaq Marketplace studio interview with John Lai, CEO / President PetVivo Holdings, Inc. (NASDAQ: PETV) (NASDAQ: PETVW) ($PETV). The Company is a biomedical gadget firm that manufactures, commercializes, and licenses modern medical units and therapeutics for companion animals. Talking with TV Host Jane King, John provides viewers an replace on the latest launch of the distribution settlement between PETV and MWI Animal Health (MWI), a number one animal well being services distributor, and Amerisource Bergen subsidiary. With over $5B in annual income, MWI is without doubt one of the largest distributors of veterinary medicine and merchandise, with a lot of business sources and expert personnel. Securos is the educational division at MWI, which supplies hands-on coaching, sources, and persevering with training for veterinarians, serving to them perceive the total advantages of merchandise. The academic and gross sales/ market groups at MWI now promote and distribute PETV’s injectable patented Spryng with OsteoCushion Technology that treats osteoarthritis and joint afflictions for canine, horses, and cats. As a naturally derived product, Spryng mimics collagen tissue that considerably improves animals’ troubled joints. The feline osteoarthritis model of Spryng is coming to market quickly. John says the Spryng roll-out with MWI goes very properly. He explains three causes for Spryng continued progress: 1) it’s a naturally derived product, 2) it’s not a pharmaceutical or organic derived product, and three) it has a recyclable package deal in keeping with ESG (Environmental, Social, and Governance) requirements. Recently, PETV employed extra seasoned personnel with over twenty years of gross sales/advertising expertise within the pet business. The on-screen QR code is obtainable throughout the present; obtain or go to PetVivo Holdings, Inc. and Spryng with OsteoCushion Technology

New to The Street TV welcomes David Luci, the President / CEO at Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ($ACXP). From the Nasdaq Marketplace studio, David talks with TV Host Jane King concerning the Company’s medical biopharmaceutical business growing a brand new class of antibiotics for bacterial infections. David discusses the Company’s novel Ibezapolstat drug, a possible remedy for Clostridioides difficile Infections (CDI). With the latest optimistic consequence from Ibezapolstat’s FDA Phase 2a medical and microbiome knowledge, the Company is now enrolling sufferers for its FDA Phase 2b trial. CDI kills about 29,000 individuals yearly; many catch the an infection in hospitals and nursing houses. Clinical knowledge to date exhibits that Ibezapolstat will increase the great microbiome micro organism within the intestine, and it demonstrated eradication of CDI throughout 3-days of remedy. David references Summit Therapeutics, and their latest Phase 3 FDA failure on a aggressive CDI drug. There has been NO new class of antibiotic medicine since 1984, and the present frontline remedy Vancomycin, has limitations with a few 15-20% fee of CDI recurrence. Big Pharma needs a brand new class of antibiotics to fight CDI and different bacterial infections. David explains that being public is crucial and helps the Company elevate cash, as wanted, going ahead with present and different pipeline remedies. Private and Governmental group grants are an excellent supply for early-stage improvement of latest novel drug merchandise. David will do a follow-up interview to inform viewers of the progress with the Ibezapolstat drug and the Company. The on-screen QR code is obtainable throughout the present; obtain or go to Acurx Pharmaceuticals, Inc.

See also  Waldencast Announces Participation in the Raymond James

From the Nasdaq Marketplace studio, New to The Street TV airs its “Unstoppable – Segment” with TV Co-Hosts Jane King and Rhonda Swan, who interview Coastal Kapital, LLC’s Kortney Murray, CEO/Founder, and Chris Murry, Senior Vice-president. Coastal Kapital, LLC is a funding supply for companies needing capital for gear purchases/leases, heavy gear, gross sales/advertising, enlargement, inventories, and different business cycle features. As a non-bank, Kortney explains her moniker “Storytime Lender”- greater than only a credit score rating. Entrepreneurs typically get financially the other way up and take a credit score hit, Coastal Kapital seems past that credit score rating however focuses on a business’s operation and the proprietor’s dedication to succeed. The business story is crucial, which might determine on lending approvals. Women-owned corporations can discover capital options at Coastal. Chris Murray, Senior Vice-President, explains Coastal Kapital’s launch into different business sectors for lending wants in e-commerce, software program options, promoting, advertising, and even ebook writers. Always in search of innovation in its lending practices which provides it a bonus over its rivals’ practices, Coastal Kapital is financing you’ll be able to belief. The on-screen QR code is obtainable throughout the present; obtain or go to Coastal Kapital, LLC

David Rojas, Chief Executive Officer / Founder of Blue Castles Ventures, LTD. (CRYPTO: BCVD) ($BCVD), is on New to The Street’s “Unstoppable – Segment.” From the Nasdaq Marketplace studio, David talks with Co-Hosts Jane King and Rhonda Swan about Blue Castles Ventures’ monetary merchandise. With experiences in day buying and selling, private/company finance, mergers and threat administration, David explains the Company’s NFT platform. The largest drawback with the crypto market is that the majority cryptos haven’t any tangible belongings backing their worth. Many have misplaced thousands and thousands of {dollars} buying and selling crypto, with DeFi Exchanges earning profits from transactional charges. David is utilizing his asset-backed stablecoin $BCVD on the ecosystem to set up an NFT market that creates an precise worth blockchain from actual collateral in belongings. Currently, Blue Venture’s creates NFTs for artwork and is growing different value-backed NFTs in several industries like actual property. The Company presents a “Crypto-Certificate,” which ensures precise possession of actual belongings on the blockchain. With a worldwide shopper base, the Blue Castle NFT platform awards a share again in $BCVD tokens for shoppers’ participation on the blockchain. The blockchain’s meant use is to create a decentralized market for the motion of products and providers, not to commerce nugatory crypto not again by something besides air. David is dedicated to future progress within the crypto business whereas creating value-added monetary merchandise backed by bodily belongings. Blue Castle Ventures LTD doesn’t commerce cryptocurrencies or perform transactions or investments with cryptocurrencies; all of the Company’s operations are in US {dollars}. The blockchain is a cryptography and safety system. The on-screen QR code is obtainable throughout the present; obtain or go to Blue Castle Ventures LTD

See also  New to The Street TV Announces Four Corporate Interviews on

About PetVivo Holdings, Inc. (NASDAQ: PETV) (NASDAQ: PETVW) ($PETV):

PetVivo Holdings Inc. (NASDAQ: PETV) (NASDAQ: PETVW) ($PETV) is an rising biomedical gadget firm targeted on manufacturing, commercializing, and licensing modern medical units and therapeutics for companion animals. The Company’s technique is to leverage human therapies for treating companion animals cost-effectively and time-efficiently. A significant part of this technique is the accelerated timeline to revenues for veterinary medical units, which enter the market a lot sooner than extra stringently regulated prescription drugs and biologics. PetVivo has a pipeline of seventeen merchandise for the remedy of animals and other people. A portfolio of 19 patents protects the Company’s biomaterials, merchandise, manufacturing processes, and strategies of use. The Company’s lead product SPRYNG with OsteoCushion expertise, a veterinarian-administered, intraarticular injection for the administration of lameness and different joint-related afflictions, together with osteoarthritis, in canine and horses, is presently accessible for industrial sale –

About Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ($ACXP):

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ($ACXP) is a clinical-stage biopharmaceutical Company targeted on growing new antibiotics for difficult-to-treat infections. The Company’s method is to develop antibiotic candidates that concentrate on the DNA polymerase IIIC enzyme. Its R&D pipeline consists of antibiotic product candidates that concentrate on Gram-positive micro organism, together with Clostridioides difficile, methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus (VRE), and drug-resistant Streptococcus pneumoniae (DRSP). The Company’s Ibezapolstat is a novel, orally administered antibiotic developed as a Gram-Positive Selective Spectrum (GPSS™) antibacterial.  It is the primary of a brand new class of DNA polymerase IIIC inhibitors underneath improvement by Acurx to deal with bacterial infections.  Ibezapolstat’s distinctive spectrum of exercise, which incorporates C. difficile however spares different Firmicutes and the vital Actinobacteria phyla, seems to contribute to sustaining a wholesome intestine microbiome. The Company accomplished Phase 1 and Phase 2a medical trials of ibezapolstat. To be taught extra about Acurx Pharmaceuticals and its product pipeline, please go to

About Coastal Kapital, LLC.

Coastal Kapital, LLC supplies companies with the capital wanted to get a aggressive edge, maximizing an organization’s income. Helping corporations succeed since 2007, Coastal Kapital account executives with over 14 years of expertise have relationships with over 150 completely different applications. Their shoppers perceive that point equals cash, and Coastal Kapital is the one-stop store for all of your monetary wants and presents its shoppers probably the most modern applications. They supply gear leasing, business loans, working capital, service provider Processing, collateral asset, and actual estate-backed funding, no matter credit score kind. Coastal Kapital is a devoted monetary service chief in industrial gear and asset-based lending and maintains relationships with business homeowners, distributors, and producers throughout the US who worth partnerships and integrity. Coastal Kapital is financing you’ll be able to belief –

See also  New Study Underscores Local Radio’s Impact for Political

About Blue Castles Ventures, LTD. (CRYPTO: BCVD) ($BCVD):

Blue Castle Ventures LTD (CRYPTO: BCVD) ($BCVD) is the primary firm on this planet to really have digital belongings which have a bodily collateral. NFTs are our fundamental traded digital asset, these NFTs have an actual portray or collateral from an actual artist. Blue Castle Ventures has its personal blockchain system to assure operations. The firm additionally has merchandise that emulate monetary planning based mostly upon the NFTs commercialization and inventory buying and selling –

About FMW Media: 

FMW Media operates one of many longest-running US and International sponsored and Syndicated Nielsen Rated programming TV manufacturers, “New to The Street,” and its blockchain present, “Exploring The Block.” Since 2009, these manufacturers have run biographical interview phase exhibits throughout main U.S. Television networks. The paid-for-TV programming platforms can doubtlessly attain over 540 million houses within the US and worldwide markets. FMW’s New to The Street / Newsmax TV broadcasting platform airs its syndication on Sundays at 10 -11 AM ET. FMW can also be one of many nation’s largest patrons of linear tv, lengthy and short-form paid programming – &

Forward-Looking Statements Disclaimer:

This press launch accommodates forward-looking statements inside Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. In some instances, you’ll be able to establish forward-looking statements by the next phrases: “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “ongoing,” “plan,” “potential,” “predict,” “project,” “should,” “will,” “would,” or the damaging of those phrases or different comparable terminology. However, not all forward-looking statements include these phrases. Forward-looking statements should not a assure of future efficiency or outcomes and won’t essentially be correct indications of the occasions at which such efficiency or outcomes are achieved. This press launch must be thought-about in all filings of the Companies contained within the Edgar Archives of the Securities and Exchange Commission at


FMW Media Contacts:

 Bryan Johnson
 +1 (631) 766-7462

“New to The Street” Business Development Office


A photograph accompanying this announcement is obtainable at


Source link


Please enter your comment!
Please enter your name here